3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
9
Head & Neck
5
Thoracic
2
Gynecologic
2
CNS
2
Sarcoma
1
Dermatologic
1
Conditions
Sarcoma
959
Glioblastoma
299
Gliosarcoma
288
Osteosarcoma
285
Brain Neoplasms
195
Dendritic Cell Sarcoma, Interdigitating
188
Gastrointestinal Stromal Tumors
180
Bone Neoplasms
172
Lymphoma
160
Central Nervous System Neoplasms
160
Astrocytoma
155
Sarcoma, Ewing
150
Glioma
148
Precursor Cell Lymphoblastic Leukemia-Lymphoma
147
Lymphoma, Non-Hodgkin
143
Burkitt Lymphoma
139
Neoplasms
137
Recurrence
134
Lymphoma, Large B-Cell, Diffuse
128
Lymphoma, Follicular
128
Neuroblastoma
126
Rhabdomyosarcoma
125
Hodgkin Disease
124
Oligodendroglioma
123
Breast Neoplasms
123
Lymphoma, Mantle-Cell
117
Leukemia, Myeloid, Acute
117
Leukemia, Lymphocytic, Chronic, B-Cell
117
Lymphoma, B-Cell, Marginal Zone
113
Leukemia
111
Interventions
Surgical Procedures, Operative
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Sarcoma
×
Clear all
NCT03116529
2024-11-04
NEXIS
University of Maryland, Baltimore
Phase 1/2
Terminated
22 enrolled